Tuesday marked the first day of evidence from the defense in Austin Thompson’s sentencing hearing. He could face life without ...
News-Medical.Net on MSN
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...
Opinion
4don MSNOpinion
Whole Hog Politics: Republicans’ alarming nosedive with white working class voters
[Watch Whole Hog Politics live: Join us today at 9 a.m. EST at TheHill.com as Chris Stirewalt and host Bill Sammon break down this week’s political news and answer questions from a live online ...
MedPage Today on MSN
Obesity Linked to Risk of Severe and Fatal Infections
About one in 10 infection-related deaths worldwide may be attributable to adult obesity ...
Arthrosi Therapeutics, Inc., headquartered in San Diego, CA, is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce ...
Increasing vaccine coverage is the key to eliminating measles, but this goal is being actively undermined by the Starmer government’s continued assault on public spending and the National Health ...
MotorTrend on MSN
We Finally Drove the Rivian R2. Is It Still Great at Half the Price?
The more affordable Rivian R2 looks to deliver on its maker’s “Adventurous Forever” motto.
The (RRP) and Virginia Tech jointly announced today the Thoroughbred Wellness Expo, which will take place on Saturday, Feb.
CURAPOD, backed by Litemed, a Made-in-India, non-invasive and personalised pain management device, has raised ₹20 crore in ...
MedPage Today on MSN
Thrombolysis Window May Extend to 24 Hours for Non-LVO Strokes
Caveat in Chinese trial was the increased symptomatic intracranial hemorrhage risk ...
Just after the close of regular trading, Edwards Lifesciences released fourth quarter and full year 2025 financial results. During today's call, management will discuss the results included in the ...
Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results